This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
11 Aug 2011

Lundbeck 2Q Revenue Grows 9%

Lundbeck's second quarter revenue of DKK 4,100 million grows 9% compared to the same period last year.

Denmark's pharmaceutical company Lundbeck has reported its second quarter revenue of DKK 4,100 million growing 9% compared to the same period last year. In constant exchange rates revenue for the quarter increased 13%.

 

The growth was driven by increasing revenue from all key products and geographic regions. Profit from operations was DKK 1,102 million, increasing 18% and corresponding to an EBIT margin of 26.9%. Operating profit before depreciation and amortisation (EBITDA) was DKK 1,250 million, increasing 4% and corresponding to an EBITDA margin of 30.5%.

 


Lundbeck's President and CEO Ulf Wiinberg said: "Again our key products deliver solid growth and during the quarter we received positive and encouraging data from t

Related News